These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3002593)

  • 21. [Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].
    Ruvalcaba-Limón E; de Jesús Garduño-Raya M; Bautista-Piña V; Trejo-Martínez C; Maffuz-Aziz A; Rodríguez-Cuevas S
    Cir Cir; 2014; 82(2):129-41. PubMed ID: 25312311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
    Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer.
    Fisher B; Costantino J; Redmond C; Fisher E; Margolese R; Dimitrov N; Wolmark N; Wickerham DL; Deutsch M; Ore L
    N Engl J Med; 1993 Jun; 328(22):1581-6. PubMed ID: 8292119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 26. Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision.
    Umpleby HC; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1988 Jul; 70(4):246-8. PubMed ID: 2843075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma.
    Huston TL; Pressman PI; Moore A; Vahdat L; Hoda SA; Kato M; Weinstein D; Tousimis E
    Breast J; 2007; 13(2):158-64. PubMed ID: 17319857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
    Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
    J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ of the breast: diagnosis and management.
    Friedrich M; Felberbaum R; Krämer S; Axt-Fliedner R; Diedrich K
    Onkologie; 2003 Dec; 26(6):588-95. PubMed ID: 14709936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma arising within fibroadenomas of the breast. A clinicopathologic study of 105 patients.
    Diaz NM; Palmer JO; McDivitt RW
    Am J Clin Pathol; 1991 May; 95(5):614-22. PubMed ID: 1850948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment.
    Rosen PP; Senie R; Schottenfeld D; Ashikari R
    Ann Surg; 1979 Mar; 189(3):377-82. PubMed ID: 218506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women.
    Nielsen M; Jensen J; Andersen J
    Cancer; 1984 Aug; 54(4):612-5. PubMed ID: 6744199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is carcinoma in situ a precursor lesion of invasive breast cancer?
    To T; Wall C; Baines CJ; Miller AB
    Int J Cancer; 2014 Oct; 135(7):1646-52. PubMed ID: 24615647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
    Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
    Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.